Nasdaq:US$17.45 (-0.03) | HKEX:HK$27.44 (+0.06) | AIM:£2.64 (+0.1)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 9 Oct 2013

Chi-Med’s Pharmaceutical R&D Business – Analyst & Investor Briefing